Comparison of T cell (CD3+) chimerism after myeloablative (MY) and nonmyeloablafive (NM) allogeneic hematopoietic stem cell transplantation (ABSCT).

被引:0
|
作者
Sobecks, Ronald
Theil, Karl
Rybicki, Lisa
Bates, Jennifer
Kalaycio, Matt
Andresen, Steven
Pohlman, Brad
Dean, Robert M.
Sweetenham, John William
Bernhard, Laura
Cherni, Kelly
Serafin, Mary
Sands, Karen
Kosar, Jennifer
Bolwell, Brian J.
机构
[1] Taussig Canc Ctr, Bone Marrow Transplant Program, Cleveland, OH USA
[2] Cleveland Clin, Quantitat Hlth Sci, Cleveland, OH 44106 USA
关键词
D O I
10.1182/blood.V108.11.2960.2960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2960
引用
收藏
页码:839A / 839A
页数:1
相关论文
共 50 条
  • [21] Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients
    S Boeck
    M Hamann
    V Pihusch
    T Heller
    H Diem
    B Rolf
    R Pihusch
    H-J Kolb
    M Pihusch
    Bone Marrow Transplantation, 2006, 37 : 57 - 64
  • [22] Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients
    Boeck, S
    Hamann, M
    Pihusch, V
    Heller, T
    Diem, H
    Rolf, B
    Pihusch, R
    Kolb, HJ
    Pihusch, M
    BONE MARROW TRANSPLANTATION, 2006, 37 (01) : 57 - 64
  • [23] Comparison of lung function after nonmyeloablative versus myeloablative allogeneic hematopoietic stem cell transplantation.
    Chien, JW
    Maris, MB
    Parimon, T
    Sandmaier, BM
    Maloney, DG
    Storb, RF
    Clark, JG
    BLOOD, 2004, 104 (11) : 360B - 360B
  • [24] Myeloablative allogeneic hematopoietic stem cell transplantation in elderly patients
    Ditschkowski, M
    Elmaagacli, AH
    Trenschel, R
    Steckel, NK
    Koldehoff, M
    Beelen, DW
    CLINICAL TRANSPLANTATION, 2006, 20 (01) : 127 - 131
  • [25] Chimerism monitoring following allogeneic hematopoietic stem cell transplantation
    S Talwar
    F Khan
    S Nityanand
    S Agrawal
    Bone Marrow Transplantation, 2007, 39 : 529 - 535
  • [26] Chimerism monitoring following allogeneic hematopoietic stem cell transplantation
    Talwar, S.
    Khan, F.
    Nityanand, S.
    Agrawal, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 (09) : 529 - 535
  • [27] SHORT-TERM CHIMERISM IN T-HELPER CELL SUBSETS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Dubnyak, D.
    Risinskaya, N.
    Drokov, M.
    Kostritsa, N.
    Kuzmina, L.
    Popova, N.
    Mikhalcova, E.
    Vasilyeva, V.
    Koroleva, O.
    Konova, Z.
    Fevraleva, I.
    Galtseva, I.
    Davydova, J.
    Kapranov, N.
    Sudarikov, A.
    Parovichnikova, E.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 861 - 861
  • [28] Utility of CD3+T- lymphocyte chimerism following myeloablative allogeneic hematopoietic stem cell transplant (HSCT): A single center experience
    Akpoguma, Andrea O.
    Dozeman, Lindsay
    Mott, Sarah C.
    De Magalhaes-Silverman, Margarida
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [29] Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?
    Jain, Tania
    Mountjoy, Luke
    Kunze, Katie L.
    Noel, Pierre
    Khera, Nandita
    Leis, Jose F.
    Slack, James L.
    Sproat, Lisa Z.
    Palmer, Jeanne
    BLOOD, 2018, 132
  • [30] Prognostic Limitations of Donor T Cell Chimerism after Myeloablative Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Wong, Eric
    Mason, Kate
    Collins, Jenny
    Hockridge, Barbara
    Boyd, Janis
    Gorelik, Alexandra
    Szer, Jeffrey
    Ritchie, David S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (05) : 840 - 844